LTB

Lymphotoxin-beta (LTB) is a T cell-derived signal that maintains the structural and functional integrity of splenic fibroblastic reticular cells (FRCs) to support T cell homing (PMID:25266629). In T cell-deficient nude mice, splenic FRCs show structural disorder and downregulated CCL19 and CCL21, and adoptive transfer of T cells restores FRC architecture and chemokine output; this rescue depends on LTB signaling through its receptor on FRCs, since receptor blockade abolishes it (PMID:25266629). Beyond (PMID:25266629), no further mechanistic detail — including the downstream signaling pathway in FRCs — has been characterized in the available corpus.

1. 2014 Medium

   Established that T cells are not merely passengers in the spleen but actively maintain the stromal scaffold, by showing that T cell-derived LTB signals to FRCs to preserve their architecture and chemokine production.

   Evidence Adoptive T cell transfer into nude mice with LTB receptor blockade, scoring FRC marker ER-TR7, CCL19/CCL21 expression, and T cell splenic homing

   PMID:25266629

   Open questions at the time

   • Single lab and single study without independent replication
   • Downstream FRC signaling pathway linking LTB receptor engagement to CCL19/CCL21 expression not defined
   • Direct biochemical demonstration of LTB binding to its FRC receptor not shown

• The intracellular signaling cascade in FRCs downstream of LTB receptor engagement, and the molecular form/partners of LTB on T cells, remain uncharacterized.
• No identification of the FRC receptor or downstream effectors in this corpus
• Role of LTB outside the splenic FRC/T cell context not addressed